RITTER PHARMACEUTICALS INC Business Finance Contracts & Agreements
79 Contracts & Agreements
- Debenture Agreements (1 contract)
- Exchange Agreements (1)
- Funding Agreements (1)
- Investor Rights Agreements (5)
- Note Agreements (5)
- Purchase Agreements (10)
- Registration Rights Agreements (6)
- Release Agreements (1)
- Share Agreements (2)
- Stock Agreements (22)
- Underwriting Agreements (2)
- Waiver Agreements (2)
- Warrant Agreements (21)
- Stock Purchase Agreement, dated July 20, 2023, by and between Qualigen Therapeutics, Inc., Chembio Diagnostics, Inc., Biosynex, S.A., and Qualigen, Inc (Filed With SEC on July 26, 2023)
- Common Stock Purchase Warrant for 2,500,000 shares in favor of Alpha Capital Anstalt, dated December 22, 2022 (Filed With SEC on December 22, 2022)
- Securities Purchase Agreement, dated December 21, 2022, by and between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt (Filed With SEC on December 22, 2022)
- 8% Senior Convertible Debenture Due December 22, 2025 (Filed With SEC on December 22, 2022)
- Registration Rights Agreement, dated December 22, 2022, by and between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt (Filed With SEC on December 22, 2022)
- Amendment No. 1 to the 2022 Employee Stock Purchase Plan of Qualigen Therapeutics, Inc (Filed With SEC on November 22, 2022)
- Qualigen Therapeutics, Inc. 2022 Employee Stock Purchase Plan (Filed With SEC on November 14, 2022)
- Master Agreement for the Operational and Technological Funding of NanoSynex between Qualigen Therapeutics, Inc. and NanoSynex Ltd., dated May 26, 2022 (Filed With SEC on June 2, 2022)
- Pre-Funded Common Stock Purchase Warrant issued by the Company in favor of Alpha Capital Anstalt, dated May 26, 2022 (Filed With SEC on June 2, 2022)
- Amended and Restated Common Stock Purchase Warrant to GreenBlock Capital LLC (300,000 shares) (Filed With SEC on May 13, 2022)
- Amended and Restated Common Stock Purchase Warrant to Christopher Nelson (300,000 shares) (Filed With SEC on May 13, 2022)
- Series B Preferred Share Purchase Agreement between the Company and NanoSynex Ltd. dated April 29, 2022 (Filed With SEC on May 13, 2022)
- Share Purchase Agreement between the Company and Alpha Capital Anstalt dated April 29, 2022 (Filed With SEC on May 13, 2022)
- Securities Purchase Agreement, dated November 29, 2021 (Filed With SEC on December 1, 2021)
- Waiver and Amendment between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt, dated November 29, 2021 (Filed With SEC on December 1, 2021)
- Securities Purchase Agreement, dated December 16, 2020 (Filed With SEC on December 18, 2020)
- Two-Year Common Stock Purchase Warrant for 1,348,314 shares, dated December 18, 2020 (Filed With SEC on December 18, 2020)
- Deferred Common Stock Purchase Warrant for 842,696 shares, dated December 18, 2020 (Filed With SEC on December 18, 2020)
- Prefunded Common Stock Purchase Warrant for 1,000,000 shares, dated December 18, 2020 (Filed With SEC on December 18, 2020)
- Securities Purchase Agreement, dated August 2, 2020 (Filed With SEC on August 4, 2020)
- Common Stock Purchase Warrant for 1,287,829 shares, dated August 4, 2020 (Filed With SEC on August 4, 2020)
- Securities Purchase Agreement, dated July 8, 2020 - corrected (Filed With SEC on July 10, 2020)
- Common Stock Purchase Warrant for 1,920,768 shares, dated July 10, 2020 (Filed With SEC on July 10, 2020)
- Pre-Funded Common Stock Purchase Warrant for 1,920,768 shares, dated July 10, 2020 (Filed With SEC on July 10, 2020)
- Securities Purchase Agreement between the Company and certain Purchasers, dated July 8, 2020 (Filed With SEC on July 9, 2020)
- Form of Warrant expected to be issued July 10, 2020 (Filed With SEC on July 9, 2020)
- Form of Pre-Funded Warrant expected to be issued July 10, 2020 (Filed With SEC on July 9, 2020)
- Form of Warrant, issued by Qualigen, Inc. in favor of GreenBlock Capital LLC and its designees, dated May 22, 2020 [pre-Merger] (Filed With SEC on May 29, 2020)
- Form of Warrant, issued by the Company in favor of GreenBlock Capital LLC and its designees, dated May 22, 2020 [post-Merger] (Filed With SEC on May 29, 2020)
- Securities Purchase Agreement, by and between Qualigen, Inc. and Alpha Capital Anstalt, dated May 20, 2020 (Filed With SEC on May 29, 2020)
- Warrant, issued by Qualigen, Inc. in favor Alpha Capital Anstalt, dated May 22, 2020 [pre-Merger] (Filed With SEC on May 29, 2020)
- Warrant, issued by the Company in favor of Alpha Capital Anstalt, dated May 22, 2020 [post-Merger] (Filed With SEC on May 29, 2020)
- Notice of Grant of Stock Option / Stock Option Agreement, by and between the Company and Andrew J. Ritter, dated as of May 18, 2020 (Filed With SEC on May 29, 2020)
- Notice of Grant of Stock Option / Stock Option Agreement, by and between the Company and Ira E. Ritter, dated as of May 18, 2020 (Filed With SEC on May 29, 2020)
- Notice of Grant of Stock Option / Stock Option Agreement, by and between the Company and John Beck, dated as of May 18, 2020 (Filed With SEC on May 29, 2020)
- Description of Common Stock (Filed With SEC on March 31, 2020)
- Form of Agreement to Exchange Warrants (Filed With SEC on February 21, 2020)
- Form of Consent and Waiver with Series B Convertible Preferred Stockholders (Filed With SEC on November 14, 2019)
- Amended and Restated Registration Rights Agreement, dated July 23, 2019, between Ritter Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on July 24, 2019)
- Amended and Restated Common Stock Purchase Agreement, dated July 23, 2019, between Ritter Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on July 24, 2019)
